You can buy or sell Organogenesis and other stocks, options, ETFs, and crypto commission-free!
Organogenesis Holdings Inc. Class A Common Stock, also called Organogenesis, is a regenerative medical company. Read More It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 10
Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
CANTON, Mass., May 10, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for its first quarter ended March 31, 2019. First Quarter 2019 Financial Summary : Net revenue of $57.1 million for the first quarter of 2019, up 60.8% compared to net revenue of $35.5 million for the ...
Available May 10, Pre-Market